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Abstract: During recent years, the possibility to create custom biocompatible nanoshapes using DNA
as a building material has rapidly emerged. Further, these rationally designed DNA structures could
be exploited in positioning pivotal molecules, such as enzymes, with nanometer-level precision.
This feature could be used in the fabrication of artificial biochemical machinery that is able to
mimic the complex reactions found in living cells. Currently, DNA-enzyme hybrids can be used
to control (multi-enzyme) cascade reactions and to regulate the enzyme functions and the reaction
pathways. Moreover, sophisticated DNA structures can be utilized in encapsulating active enzymes
and delivering the molecular cargo into cells. In this review, we focus on the latest enzyme systems
based on novel DNA nanostructures: enzyme reactors, regulatory devices and carriers that can find
uses in various biotechnological and nanomedical applications.
Keywords: DNA nanotechnology; DNA origami; self-assembly; enzyme; cascade reactions; DNA
nanodevice; DNA sensors; drug-delivery; nanomedicine
1. Introduction
In order to maintain complex metabolic pathways, nature uses compartmentalization and spatial
organization of metabolically active units to separate specialized functions, control activity and gain
specificity. In the cell, specific organelles control the location and crowding of enzymes, which has a
profound effect on their spatial action, and ultimately allows different metabolic pathways to operate
at the same time in close proximity, but in different compartments. For example, electron transport
and oxidative phosphorylation are handled by the mitochondrion, whereas at the same time glycolysis
and fatty acid biosynthesis take place in the cytosol. Furthermore, multiple enzymes responsible for
the individual reaction steps in a metabolic pathway are often combined into a single multifunctional
enzyme or complex in order to enhance and control the reaction cascade or cycle. Fatty acid synthase
is one of the prime examples: in animals it combines two identical protein chains that contain seven
different catalytic activities required for the biosynthesis of fatty acids.
Although highly desirable, the programming of chosen reaction cascades and creating artificial
systems that can position and confine different enzymes is still far from the complexity achieved by
nature. Controlling chemical reactions by using self-assembled nanoscale reactors has consequently
emerged as an active area of research [1]. Simple compartmentalization of enzymes has already been
achieved by using different nanoscale reactors. Examples of such systems include sol-gel materials [2],
polymersomes [3], protein cages [4–6] and crystalline structures [7–9]. Porous polymersomes were
used as nanoreactors to anchor three different enzymes into separate locations: the lumen, bilayer
membrane and surface. Protein cages, such as virus-like particles, have been utilized to pack different
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enzymes that perform a coupled cascade reaction densely inside a porous protein shell. Finally,
for example, metal-organic frameworks have been designed to trap and encapsulate enzymes and
shown to prevent their aggregation and denaturation. All of the above-mentioned systems are prime
examples on how the positioning, separation and clustering of enzymes can be controlled.
In this review, we focus on complexes and systems that involve functional enzymes and novel
DNA nanostructures (an example of such a system is depicted in Figure 1). These sophisticated DNA
nanostructures can be programmed to form precise and controllable arrangements of enzymes at the
nanoscale, and these systems are particularly engaging for various applications in bioengineering and
nanomedicine. We have divided this review into four main sections. First, we briefly summarize the
development in structural DNA nanotechnology and discuss how DNA motifs can be combined with
functional enzymes (Section 2). Section 3 is devoted to (static) enzymatic nanoreactors, and Section 4
covers the enzymatic regulatory devices with mechanical function. Finally, in Section 5, containers and
carriers for protecting and delivering enzymes are discussed.
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Figure 1. A schematic view of an enzymatic nanoreactor built from DNA ([S] = substrate, [P] = product). 
By taking advantage of the high addressability and modularity of the DNA nanostructures, enzymes 
can be attached and arranged with nanometer-scale precision. As an example, glucose oxidase (GOx, 
purple)–horseradish peroxidase (HRP, green) cascade pairs have been assembled into a confined 
reaction space provided by two tubular DNA origami nanostructures (orange and yellow cages). 
2. Building with DNA Molecules and Enzymes 
2.1. DNA Nanostructures 
Nadrian ‘Ned’ Seeman postulated around 30 years ago that deoxyribose (DNA) molecules could 
be used as building material in creating complex predesigned nanostructures through molecular self-
assembly [10]; sequence-complementary parts of single-stranded DNA (ssDNA) molecules can be 
hybridized into double-stranded DNA (dsDNA) domains (via Watson-Crick base-pairing) and 
therefore into larger programmed shapes. Since then, structural DNA nanotechnology has enjoyed a 
rapid progress; numerous complex nanostructures and different fabrication techniques have been 
introduced [11] (Figure 2). A great deal of the first compelling DNA assemblies were based on tile-
like structures that enabled fabrication of two-dimensional (2D) [12] and three-dimensional (3D) 
crystals [13], but nevertheless, the huge upturn in the field was the invention of the ‘DNA origami’ 
technique [14] (Figure 2a). The origami approach is based on folding a long single-stranded DNA 
scaffold strand into a desired shape with the help of a set of short oligonucleotides (staples), and it 
has now become a widely accessible and exploited method to fabricate custom, modular and spatially-
well-defined 2D [14] and 3D nanostructures with complex curvatures, bends and twists [15–18] (see 
Figure 2b,c). Later on, methods based on scaffold-free fabrication [19] (Figure 2d), polyhedral rendering 
[20,21] (Figure 2e) and shape-complementarity [22] (Figure 2f) were introduced. 
Figure 1. A schematic view of an enzymatic nanoreactor built from DNA ([S] = substrate, [P] = product).
By taking advantage of the high addressability and modularity of the DNA nanostructures, enzymes
can be attached and arranged with nanometer-scale precision. As an example, glucose oxidase
(GOx, purple)–horseradish peroxidase (HRP, green) cascade pairs have been assembled into a confined
reaction space provided by two tubular DNA origami nanostructures (orange and yellow cages).
2. Building with DNA Molecules and Enzymes
2.1. DNA Nanostructures
Nadrian ‘Ned’ Seeman postulated around 30 years ago that deoxyribose (DNA) molecules could
be used as building material in creating complex predesigned nanostructures through molecular
self-assembly [10]; sequence-complementary parts of single-stranded DNA (ssDNA) molecules can
be ybridized into double-stranded DNA (dsDNA) domains (via Wats n-Crick base-pairing) and
therefore into larger programmed shapes. Since then, structural DNA nanotec ology s enjoyed
a rapid progress; numerous complex n nos ructures and d fferent fabrication techniques have been
introduced [11] (Figure 2). A great deal of the first compelling DNA assemblies were based on
tile-like structures that enabled fabrication of two-dimensional (2D) [12] and three-dimensional
(3D) crystals [13], but nevertheless, the huge upturn in the field was the invention of the ‘DNA
origami’ technique [14] (Figure 2a). The origami approach is based on folding a long single-stranded
DNA scaffold strand into a desired shape with the help of a set of short oligonucleotides (staples),
and it has now become a widely accessible and exploited method to fabricate custom, modular
and spatially-well-defined 2D [14] and 3D nanostructures with complex curvatures, bends and
twists [15–18] (see Figure 2b,c). Later on, methods based on scaffold-free fabrication [19] (Figure 2d),
polyhedral rendering [20,21] (Figure 2e) and shape-complementarity [22] (Figure 2f) were introduced.
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Figure 2. (a) A DNA origami technique. A long scaffold strand is folded into a desired shape with the 
help of short staple strands [14]; (b) Multilayer DNA origami in square and honeycomb lattice [15,16]; 
(c) DNA origami with curvatures and bends [17,18]; (d) Scaffold-free fabrication of DNA nanoshapes. 
Numerous target shapes can be fabricated by selecting subsets of strands from the cubic-like 
‘molecular canvas’ [19]; (e) A fully automated top-down design method to create meshed DNA 
origami structures [21]; (f) DNA origami structures can be glued together by taking advantage of the 
blunt-end stacking and the shape-complementarity of the origami units [22]. (a) is reproduced with 
permission from [14]. Copyright Nature Publishing Group, 2006. (b) is reproduced with permission 
from [16]. Copyright Nature Publishing Group, 2011. A sphere in (c) is reproduced with permission 
from [17]. Copyright The American Association for the Advancement of Science, 2011. A gear-like 
object in (c) is reproduced with permission from [18]. Copyright The American Association for the 
Advancement of Science, 2009. (d) is reproduced with permission from [19]. Copyright The American 
Association for the Advancement of Science, 2012. (e) is reproduced with permission from [21]. 
Copyright The American Association for the Advancement of Science, 2016. (f) is reproduced with 
permission from [22]. Copyright The American Association for the Advancement of Science, 2015. 
In general, the DNA-based assembly of nanostructures is a highly parallel technique, and the 
nanometer-scale addressability of the created objects makes it an intriguing approach for developing 
novel bionanotechnological applications [11]. To date, loads of implementations based on DNA 
nanostructures have been presented, such as tunable plasmonic devices and metallic nanoshapes 
[23,24], rulers for optical imaging [25], structures for nanoelectronics [26,27], artificial ion channels 
for transporting or sequencing molecules [28], and nanorobots for targeted drug delivery [29]. 
Moreover, as discussed in this review, DNA nanostructures provide an excellent foundation for 
designing enzymatic reactors and complex catalytic systems at the nanoscale. 
2.2. DNA-Enzyme Conjugates and Arrays 
As discussed above, DNA structures can be used as templates for various molecules, inorganic 
nanoparticles, and equally for functional enzymes [30]. Enzymes can be conjugated directly to an 
oligonucleotide (part of a DNA structure) or they can be attached to DNA through a specific binding 
motif [30]. In general, it is important that the enzyme activity is retained in the conjugation; a chosen 
enzyme should not be modified chemically or genetically [31]. For example, sequence-specific DNA-
binding proteins can be used as adaptors in attachment [32], and their use can help to maintain the 
enzyme activity in the conjugation. 
To date, there exist numerous reports of utilizing simple nucleic acid motifs to assemble 
functional enzymes and to organize chemical reactions with programmability [33–36]. In addition, it 
has been shown that by utilizing DNA-based self-assembly, structurally-well-defined protein arrays 
[30,37] and DNA-enzyme crystals [7] can be created. Along these lines, this review discusses recent 
progress in creating smart enzyme reactors, dynamic regulators, protein containers and carriers by 
taking advantage of state-of-the-art DNA nanostructures, such as DNA origami. 
3. Enzyme Reactors and Cascades 
Figure 2. (a) A origami technique. A long scaffold strand is folded into a desired shape
with the help of short staple strands [14]; (b) Multilayer DNA origami in square and honeycomb
lattice [15,16]; (c) DNA origami with curvatures and bends [17,18]; (d) Scaffold-free fabrication of
DNA nanoshapes. Numerous target shapes can be fabricated by selecting subsets of strands from the
cubic-like ‘molecular canvas’ [19]; (e) A fully automated top-down design method to create meshed
DNA origami structures [21]; (f) DNA origami structures can be glued together by taking advantage of
the blunt-end stacking and the shape-complementarity of the origami units [22]. (a) is reproduced with
permission from [14]. Copyright Nature Publishing Group, 2006. (b) is reproduced with permission
from [16]. Copyright Nature Publishing Group, 2011. A sphere in (c) is reproduced with permission
from [17]. Copyright The American Association for the Advancement of Science, 2011. A gear-like
object in (c) is reproduced with permission from [18]. Copyright The American Association for the
Advancement of Science, 2009. (d) is reproduced with permission from [19]. Copyright The American
Association for the Advancement of Science, 2012. (e) is reproduced with permission from [21].
Copyright The American Association for the Advancement of Science, 2016. (f) is reproduced with
permission from [22]. Copyright The American Association for the Advancement of Science, 2015.
I gen al, the DNA- ased ass mbly of nanostructures is a highly a allel technique, and
the nanometer-scale addressability of the created objects makes it an intriguing approach for
developing novel bionanotechnological applications [11]. To date, loads of implementations based
on DNA nanostructures have been presented, such as tunable plasmonic devices and metallic
nanoshapes [23,24], rulers for optical imaging [25], structures for nanoelectronics [26,27], artificial ion
channels for transporting or sequencing molecules [28], and nanorobots for targeted drug delivery [29].
Moreover, as discussed in this review, DNA nanostructures provide an excellent foundation for
designing enzymatic reactors and complex catalytic systems at the nanoscale.
2.2. DN -Enzyme Conjugates and Arrays
As discussed above, DNA structures can be used as templates for various molecules, inorganic
nanoparticles, and equally for functional enzymes [30]. Enzymes can be conjugated directly to
an oligonucleotide (part of a DNA structure) or they can be attached to DNA through a specific
binding motif [30]. In general, it is important that the enzyme activity is retained in the conjugation;
a chosen enzyme should not be modified chemically or genetically [31]. For example, sequence-specific
DNA-binding proteins can be used as adaptors in attachment [32], and their use can help to maintain
the enzyme activity in the conjugation.
To date, there exist numerous reports of utilizing si ple nucleic acid motifs to assemble functional
enzymes a to orga ize chemic l reactions with programmability [33–36]. In addition, it has been
shown that by utilizing DNA-based self-as embly, struct rally-well-defined protei arrays [30,37]
and DNA-enzyme crystals [7] can be created. Along hese lines, this review discusses recent progress
in creating smart enzyme reactors, dynamic regulators, protein containers and carriers by taking
advantage of state-of-the-art DNA nanostructures, such as DNA origami.
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3. Enzyme Reactors and Cascades
An enzyme reactor typically contains one or more enzymes, which catalyze a desired
reaction. The purpose of the enzyme reactor is usually to maximize the reaction efficiency via
compartmentalization or by bringing the reaction counterparts in close proximity to each other.
By utilizing designed DNA nanostructures with high addressability, enzymes can be attached to them
with nanoscale precision. This is a key factor for enzyme functions; a substrate can only bind to an
enzyme in a specific orientation, and on the other hand, the proximity of the compounds provided
by the DNA templates could significantly enhance the enzymatic reaction rates [38,39]. In addition,
it is essential to control the channeling of the substrate and the reaction intermediates of the enzyme
cascades [40]. In many cases, compartmentalization could be used to efficiently separate and arrange
simultaneous reactions and reaction compounds similar to complex natural systems [41]. Moreover,
enzyme reactors can be equally utilized to study enzyme functions and reaction pathways [42]. In this
section, recent examples of using DNA nanostructures to build (static) nanoreactors for biosensing
and molecular-scale diagnostics are discussed (see also Table 1).
Table 1. Examples of DNA-based enzyme reactors and cascades.
Type Function Key Aspects
A glucose oxidase (GOx) – horseradish
peroxidase (HRP) cascade on
a DNA origami [43].
The enzyme positions on the DNA
origami template can be tuned.
The cascade activity is highly dependent on
the spacing between the enzymes; the highest
activity was found at a 10 nm distance.
A GOx-HRP cascade on a DNA
origami that can be rolled into
tubular shape [44].
The idea is similar to the above,
but here the semi-confined tubular
geometry could enable shielding.
The enzymes in the semi-confined
geometry show higher enzymatic
activity than the free enzyme controls.
A swinging arm between malate
dehydrogenase (MDH) and
glucose-6-phosphate dehydrogenase
(G6pDH) assembled on a
double-crossover (DX) DNA tile [45].
The DNA strand acts as a flexible arm that
channels the cofactor transfer between the
hydrogenases in the complex.
The enzyme activity achieved by the
swinging arm is significantly higher
than in the case of freely diffusing cofactor.
A tubular DNA origami nanoreactor
with GOx-HRP pairs [46].
The nanoreactor is comprised of
two units: GOx- and HRP-loaded
DNA origamis that can be combined
into a complete cascade reactor.
Single origami units and the complete
reactor equipped with binding sites
show higher activity than the
controls without binding sites.
A xylose reductase (XR) – xylitol
dehydrogenase (XDR) cascade on a
DNA origami [47].
The enzymes are attached to origami via
DNA-binding protein adaptors resulting
in an artificial enzyme cascade.
The efficiency of the cascade reaction is more
dependent on the interenzyme distance than
that of the cascade reaction with unimolecular
transport between two enzymes.
A three-enzyme pathway assembled by
a DNA nanostructure [48].
MDH, oxaloacetate decarboxylase (OAD)
and lactate dehydrogenase (LDH) are
organized at the corners of the triangular
DNA nanostructure, thus forming a
three-enzyme cascade.
Activity of the cascade depends more on
the geometric patterns of enzymes than
the interenzyme spacings.
In the enzyme cascade system presented in Figure 3a, glucose oxidase (GOx) catalyzes the
oxidization of glucose (substrate) in the presence of oxygen to generate gluconic acid and a hydrogen
peroxide (H2O2) intermediate, which, in turn, serves as a substrate for horseradish peroxidase (HRP)
(HRP reduces H2O2 into water). Simultaneously, the presence of H2O2 results in the protonation of the
ABTS2´ (2,21-azinobis-(3-ethylbenzthiazoline-6-sulfonate) dianion, and hence, an ABTS´ radical anion
is generated (ABTS´ acts as a reporter of the enzyme activity). The diffusion distance of the hydrogen
peroxide limits the rate of this enzyme cascade reaction since HRP has a much higher turnover rate
than GOx. Fu et al. studied interenzyme substrate diffusion by using a rectangular DNA origami
tile as a platform to preorganize GOx-HRP pairs in a distance-dependent manner [43]. The highest
cascade activity was obtained when the interenzyme distance was 10 nm. Importantly, the activity was
about 15 times higher than the control sample that contained unbound enzymes. A drastic decrease in
activity was observed as the interenzyme distance was adjusted to 20 nm, and the activity was further
decreased gradually as the distance was increased up to 65 nm.
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reductase (XR) and xylitol dehydrogenase (XDR)) performing a cofactor coupled cascade reaction on 
DNA origami [47]; (f) An artificial three-enzyme (lactate dehydrogenase (LDH), MDH and 
oxaloacetate decarboxylase (OAD)) pathway organized using a DNA nanostructure [48]. (a) is 
reproduced with permission from [43]. Copyright American Chemical Society, 2012. (b) is reproduced 
with permission from [44]. Copyright American Chemical Society, 2013. (c) is reproduced with 
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Inspired by the above-mentioned work, Fu et al. [44] designed rectangular (100 nm × 70 nm) 
DNA tiles with GOx-HRP cascade pairs precisely positioned 15 nm apart from each other. By using 
sticky-end extensions on the top and bottom edges of the DNA origami rectangles, they induced the 
tile to form short DNA nanotubes (Figure 3b). Efficiency of the enzyme cascade reaction was 
quantitatively measured using an excess amount of reactant glucose and the chromogenic reaction of 
the reporter ABTS2− (substrate for HRP). The activity was highest when the enzymes were located in 
a confined nanospace within the DNA nanotube. When the enzymes were attached to the 
semiconfined planar DNA tile, the activity was lower, but still higher than that of free cascade 
controls, which showed the lowest activity. Hence, these nanoscale bioreactors provide access to an 
artificial system for studying biological processes in organized cell-mimicking environments. 
Swinging arms are key constituents of sequenced catalytic transformations in many naturally 
occurring multi-enzyme complexes. The arm is commonly a chemical group covalently attached to the 
Figure 3. (a) A glucose oxidase (GOx) – horseradish peroxidase (HRP) enzyme cascade pair assembled
on a rectangular DNA origami [43]; (b) A rectangular DNA origami shape with attached enzyme
cascade pairs (GOx and HRP) can be rolled into tubular shapes [44]; (c) A swinging arm for cofactor
transfer between the enzymes (malate dehydrogenase (MDH) and glucose-6-phosphate dehydrogenase
(G6pDH)) assembled on a DNA tile [45]; (d) A modular and tubular DNA origami-based enzyme
cascade (GOx and HRP) nanoreactor [46]; (e) An artifical enzyme cascade (xylose reductase (XR) and
xylitol dehydrogenase (XDR)) performing a cofactor coupled cascade reaction on DNA origami [47];
(f) An artificial three-enzyme (lactate dehydrogenase (LDH), MDH and oxaloacetate decarboxylase
(OAD)) pathway organized using a DNA nanostructure [48]. (a) is reproduced with permission
from [43]. Copyright American Chemical Society, 2012. (b) is reproduced with permission
from [44]. Copyright American Chemical Society, 2013. (c) is reproduced with permission from [45].
Copyright Nature Publishing Group, 2014. (d) is reproduced with permission from [46]. Published by
The Royal Society of Chemistry, 2015. (e) is reproduced with permission from [47]. Copyright American
Chemical Society, 2016. (f) is reproduced with permission from [48]. Copyright Joh Wiley and
Sons, 2016.
Inspired by the above-mentioned work, Fu et al. [44] designed rectangular (100 nm ˆ 70 nm)
DNA tiles with GOx-HRP cascade pairs precisely positioned 15 nm apart from each other. By using
sticky-end extensions on the top and bottom edges of the DNA origami rectangles, they induced
the tile to form short DNA nanotubes (Figure 3b). Efficiency of the enzyme cascade reaction was
quantitatively measured using an excess amount of reactant glucose and the chromogenic reaction of
the reporter ABTS2´ (substrate for HRP). The activity was highest when the enzymes were located in a
confined nanospace within the DNA nanotube. When the enzymes were attached to the semiconfined
planar DNA tile, the activity was lower, but still higher than that of free cascade controls, which
showed the lowest activity. Hence, these nanoscale bioreactors provide access to an artificial system
for studying biological processes in organized cell-mimicking environments.
Swinging arms are key constituents of sequenced catalytic transformations in many naturally
occurring multi-enzyme complexes. The arm is commonly a chemical group covalently attached
to the enzyme complex via a flexible linker that enables the direct transfer of substrate molecules
between multiple active sites within the complex. Fu et al. [45] constructed a DNA nanostructure for
assembling a multi-enzyme system that is equipped with an artificial swinging arm. The arm was
designed to efficiently channel hydride transfer between two dehydrogenases. The whole design
is illustrated in Figure 3c. The nanostructure complex utilized a two-enzyme cascade composed of
glucose-6-phosphate dehydrogenase (G6pDH) and malic dehydrogenase (MDH) positioned on a
DNA double-crossover (DX) tile scaffold. In the cascade sequence G6pDH catalyzes the oxidation
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of glucose-6-phosphate and the reduction of NAD+ (nicotinamide adenine dinucleotide, oxidized)
to NADH (nicotinamide adenine dinucleotide, reduced). In the second cycle, MDH catalyzes the
reduction of oxaloacetate to malic acid using the NADH produced by G6pDH. The swinging arm,
an NAD+-equipped poly-thymine (poly-T) oligonucleotide (20 nucleotides long), was adhered to the
DNA tile surface exactly halfway between the anchored enzymes G6pDH and MDH. The swinging
arm’s capability to boost dehydrogenase activity in complexes containing one enzyme coupled to a
single NAD+ arm was measured individually in bulk solution for three distances (7, 14 and 21 nm).
The highest activity for both G6pDH and MDH was observed at the 7 nm distance showing ca. 25-fold
enhancement of activity compared to an enzyme system in the presence of the same concentration
(100 nM) of freely diffusing NAD+. In the same experimental conditions, the activity of the fully
assembled G6pDH–NAD+–MDH two-enzyme nanostructure with a swinging arm is ca. 90-fold higher
than that obtained using the same two-enzyme complex but with freely diffusing NAD+.
Linko et al. [46] designed and fabricated an enzyme reactor, which consists of two distinct tubular
3D DNA origami building blocks with either GOx or HRP enzymes anchored inside the origami
compartment through biotin–NeutrAvidin (NTV) binding (Figure 3d). Both units were fabricated
separately, and ‘glued’ together via a programmable DNA base-pairing by hybridizing 32 short (three to
six bases) sequences. The short sequences that were sticking out at the end of one unit were paired with
free scaffold sites located at the edge of another unit. The other end of the origami unit was passivated
by overhanging single-stranded poly-T sequences (8 nucleotides) in order to prevent the formation
of multimers. The catalytic activity of a two-unit nanoreactor was monitored in the environment
containing excess amounts of D-glucose as a reactant and 3,31,5,51-tetramethylbenzidine (TMB) as a
reporter in order to achieve a reaction that is restricted by the diffusion rate of the intermediate product
H2O2. Compared to the control samples (similarly prepared samples but without NTV binding sites
for enzymes), the assembled twin-unit nanoreactor has much higher activity, thus indicating that
unspecific binding between enzymes and origami structures is insignificant.
Ngo et al. [47] introduced cofactor-coupled cascade reactions on a DNA origami scaffold.
The cascade was based on the D-xylose metabolic pathway, and combined two enzymes: xylose
reductase (XR) and xylitol dehydrogenase (XDR). The enzymes were attached to the DNA scaffold
with DNA-binding protein adaptors, the zinc finger protein (zif268) and the basic leucine-zipper
protein (GCN4). The cascade mechanism relies on the recycling of cofactor NADH between the
enzymes, which is possible due to their close proximity. Within the metabolic pathway of xylose,
the first enzyme XR converts xylose into xylitol by consuming the cofactor NADH. The produced
xylitol and NAD+ are both simultaneously transported to the second enzyme XDH, which converts
xylitol into xylulose by consuming NAD+ to recycle the NADH cofactor (Figure 3e).
Liu et al. [48] assembled an artificial three-enzyme pathway on a series of DNA nanoscaffolds in
order to study the dependence of their activities. They measured the activities of an MDH-OAD-LDH
(malate dehydrogenase–oxaloacetate decarboxylase–lactate dehydrogenase) cascade with variable
spatial distances and geometric arrangements. The three-enzyme pathway (Figure 3f) starts with the
MDH-catalyzed oxidation of malic acid to oxaloacetate (OAA) and the simultaneous reduction of
NAD+ to NADH. In the next cycle OAD converts OAA into pyruvic acid and inhibits its conversion
back to malic acid. In the third cycle LDH consumes the reduced NADH and pyruvic acid to produce
lactic acid. Unlike the above-mentioned two-enzyme systems, the overall activity of the three-enzyme
pathway was more dependent on the geometric patterns that arranged enzymes within a short distance
(10–30 nm) of each other rather than with interenzyme spacings. By optimizing the geometric patterns
of the three enzymes, a five-fold activity enhancement was obtained compared to the unassembled free
enzymes. In addition, the depletion of the pathway intermediates was very efficient in the assembled
enzyme systems with little detectable NADH in the bulk solution, indicating that nearly all NADH
was coupled into the enzyme pathway without leakage.
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4. Enzymatic Nanodevices with Motion
Besides the static nanoreactors discussed in the previous section, there are compelling examples
of in vitro nanodevices that can control enzyme activity. These devices can be switched between an
active and inactive state by introducing a specific trigger. The triggers are usually DNA strands that are
able to perform preprogrammed strand displacement reactions. Alternatively, some of the systems can
autonomously regulate the reaction(s). Here, a few examples of mechanical regulatory DNA-enzyme
devices, autonomous molecular systems and their working principles are reviewed (see also Table 2).
Table 2. Examples of mechanical regulatory DNA-enzyme devices.
Type Function Key Aspects
DNA nanotweezers [49–52]
equipped with cascade pairs or
with the enzyme and its cofactor.
The tweezers can be opened and closed
through a strand-displacement reaction.
The enzyme activity can be controlled
by switching the tweezers reversibly.
A tubular DNA origami
nanoreactor [53].
The lid of the tube can be
opened and closed with the
help of lock and key strands.
Flowthrough of the compounds
into the confined reaction chamber
is controlled by the lid.
A four-arm DNA origami
nanoactuator [54].
A distance change in a driver site can be
propagated to the mirror site containing
binding sites for cargo molecules.
The actuator can be driven using different
mechanisms, and it can be used for, e.g.,
tuning fluorescence behavior of enhanced
fluorescent protein (eGFP).
Aptamer-based logical circuit [55].
The autonomous logical circuit
controls α-thrombin activity
through the convertor, controller
and generator modules.
α-thrombin aids blood coagulation, and
therefore systems such as this may find
intriguing biomedical uses.
4.1. Mechanical Regulatory DNA-Enzyme Devices
Liu et al. [49] employed a DNA tweezer nanostructure to actuate the reaction between a
G6pDH/NAD+ enzyme-cofactor pair. In this construct (Figure 4a), the enzyme and cofactor were
attached to two different ca. 14-nm-long arms. Actuation of the enzyme function was achieved by
switching between open and closed states of the tweezers, in other words by spatially separating the
enzyme-cofactor pair for inhibition or bringing the pair together for activation, respectively. In the
reaction cycle, NAD+ is first reduced to NADH by G6pDH. Then, phenazine methosulfate (PMS)
catalyzes electron transfer from NADH to resazurin, which produces strongly fluorescent resorufin.
In the tweezer geometry, a 25-nucleotide (nt) ssDNA oligomer connected the ends of the tweezer arms
and served as a structural regulatory element to control the state of the system. The open state can
be attained by disrupting the hairpin via hybridization between a complementary set strand and a
hairpin, thus generating a rigid ca. 16-nm-long dsDNA domain between the ends of the tweezer arms.
By adding a fuel strand (fully complementary to the set strand) to the system, a hairpin is released by a
strand-displacement mechanism and the tweezers are switched back to the closed state. Opening and
closing mechanisms have been further optimized by Dhakal et al. [50].
Moreover, Xin et al. [51] used similar nanotweezers and chose the GOx-HRP cascade as a model
to demonstrate the reversible regulation of the enzyme cascade reaction. The DNA machine was
comprised of double-crossover (DX) motifs, which formed two rigid arms (glued together by an
immobile four-way junction). A DNA motor, which can switch between a stem-loop and a double-helix
structure driven by a strand displacement reaction, was incorporated into the middle of the DNA
machine to cycle between open and closed states. This kind of device could also be used to reversibly
regulate the target binding affinity of a thrombin protein, as shown by Chou et al. [52].
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to control the flowthrough of the reaction compounds [53]; (c) DNA origami nanoactuator that can be
driven by, e.g., single-stranded DNA (ssDNA) strands or restriction enzymes [54]; (d) Aptamer-based
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Publishing Group, 2016. (d) is reproduced with permission from [55]. Copyright American Chemical
Society, 2012.
Wang et al. [53] prepared a DNA origami nanochannel as a scaffold for monitoring the GOx-HRP
cascade reaction. The channel, 100 nm in length and 22 nm in diameter, was formed by rolling up a
rectangular origami object with the help of sticky ends, placed as extensions at the top and bottom
helices of the sheet-like structure (depicted in Figure 4b). A row of 11 staple strands, called shutter
strands, which contain 15 nucleotid s long overhangs in an upright position to the c ncave side,
formed a shutter at the end of the nanochannel which can control the opening and closing of the
channel upon stimuli. By adding the ‘lock strands’, i.e., ssDNA molecules complementary to the
15 nt overhangs, rigid DNA duplexes were formed, resulting in an efficient closing of the shutter.
Reopening the nanochannel was achieved by using fully complementary ‘key strands’. The key strands
hybridized with the lock strands, displacing them from the channel and therefore opening the shutter.
Reversibility of the shutter mechanism was demonstrated with the sequential addition of 23 nt lock
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and key strands, performing a cycle change: open-close-open. The cycle was monitored with UV-vis
spectroscopy; when the shutter was closed, the efficiency of the cascade reaction in the nanochannel
dropped, indicating that the flow of substrates was efficiently obstructed.
Ke et al. [54] developed a nanoactuator (shown in Figure 4c) that consists of four stiff,
10-helix-bundle arms, assembled into a rhombus shape. The actuator is equipped with a mechanical
linkage in each corner to enable movement of the one half (the driver, left side) to be expressed at
the other half (the mirror, right side). The arms in the design are connected with two single-stranded
scaffold segments (light blue), and the strut length (left side) can be adjusted by hybridizing the
segments with ‘strut-locking’ strands of predetermined lengths (lower panel in Figure 3c). Both arms
on the right side contain short ssDNA extensions that enable immobilization of cargo molecules
(green strands). By attaching split enhanced green fluorescent protein (eGFP) to the actuator,
the authors constructed a DNA-protein hybrid nanostructure, which showed tunable fluorescent
behaviors via long-range allosteric regulation (the binding of an effector molecule controls the
global shape of the protein). Moreover, the nanoactuator could find uses as a stimuli-specific sensor.
The stimuli can be a change in the buffer compounds or for example the introduction of restriction
enzymes (such as restriction endonuclease BamHI).
4.2. Autonomous Molecular Systems
DNA nanostructures can be used to control enzymes that are free in the environment.
Autonomous molecular systems are able to sense the environment, process the information by a
predefined signal-processing algorithm, and finally act based on the results of the computation.
Using autonomous molecular systems, the concentration and/or activity of enzymes could be
controlled in cells or extra-cellular liquids. These artificial biochemical circuits may enable boolean
processing and programmability, and they could also be exploited to monitor chemical reactions and
to regulate gene expressions. Briefly, it is possible to perform logic gate operations, amplify and
restore signals, create cascades and construct feedback loops. This is all based on programmable
nucleic acid base-pairing interactions. Aptamers (special single-stranded oligonucleotides), based
on their secondary and tertiary structures, have the potential to specifically interact with enzymes,
other proteins and molecules as well as with viruses and cells. Aptamers can also regulate enzyme
activity and other protein functions.
As an example of an autonomous regulator, we describe a logical molecular circuit to control
α-thrombin activity. The circuit by Han et al. [55] and its working principle are depicted in Figure 4d.
The enzyme α-thrombin is a protease that aids blood coagulation by converting fibrinogen to fibrin.
The circuit is based on ssDNA strand displacement reactions and includes three modules: (a) the
input convertor that converts the thrombin input into a DNA sequence that is used later in the cascade
reactions of the system; (b) the threshold controller that sets the threshold concentration to preserve
the regular throbmin activity level; and (c) the inhibitor generator that suppresses excessively high
thrombin activity once the activity surpasses the threshold value. The full circuit is depicted in
Figure 4d. The input convertor is a duplex consisting of a TA-29 aptamer and an ssDNA molecule
(Aptamer-Input in Figure 4d). A thrombin molecule can bind to the TA-29 and therefore displace the
ssDNA. In this way, the thrombin input is converted to an ssDNA input that could be read by the later
modules of the circuit. When the ssDNA input enters the threshold controller, it results in an inert
ssDNA molecule (Waste in Figure 4d) through a toehold-exchange reaction of the ssDNA input and the
threshold duplex (Threshold in Figure 4d). If the concentration of the ssDNA input is higher than the
predetermined threshold concentration, the excess ssDNA input enters the inhibitor generator, which
is also based on toehold-exchange reactions. The order of these two reactions/modules is determined
by the differences in the thermodynamic stability and the reaction kinetics of the DNA strands. In this
case, a longer toehold makes the threshold reaction more favorable.
The inhibitor generator module generates an ssDNA output (S in Figure 4d) as the ssDNA input
displaces it from an output duplex (Output in Figure 4d). The signal is amplified with the catalytic
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help of fuel strands (Fuel in Figure 4d). The fuel strand displaces the ssDNA input from the duplex,
thereby releasing the input to react with another output duplex. Thus, a single input can produce
multiple outputs. Finally, the amplified ssDNA output (S) reacts with a duplex that involves a TA-15
aptamer (Generator in Figure 4d). TA-15 is released, and subsequently it binds to the fibrinogen exosite
of the thrombin molecule, inhibiting its activity. Overall, this system serves as a compelling example
of an autonomous DNA-based enzyme system, but the sustainability of the system still remains a
challenge. The system was not able to recycle the DNA-based cascade components and the modules
needed constant administration.
5. Enzyme Containers and Carriers
As seen above, DNA nanostructures could perform preprogrammed tasks and efficiently react
to triggering signals. These features could be extremely useful in nanomedical applications, such as
delivering enzymes into cells (e.g., in enzyme replacement therapy). In general, delivering enzymes
into cells can be rather challenging since the transport efficiency is charge- and size-dependent.
In addition, one of the concerns is that the stability of enzymes may be easily compromised, which
could lead to malfunctioning. However, by using designed and biocompatible DNA nanostructures as
carriers, the cargo could be protected and released in a controllable way. In this section we discuss
the desired properties of DNA containers and review potential DNA nanostructures and protection
mechanisms that could find uses in efficient intracellular delivery of enzymes (see also Table 3).
Table 3. Examples of DNA-based enzyme containers and carriers.
Type Function Key Aspects
Hollow DNA origami
containers [56–58].
These structures could be used in
encapsulating molecular cargo.
Examples include successful
opening and closing mechanisms
for conceivable drug release.
DNA origami half-cages [59] that
can be arranged into a closed box.
The closed geometry shields the
enzymatic reactions (such as the glucose
oxidase (GOx) – horseradish peroxidase
(HRP) cascade) against proteases.
Activity of a single enzyme can be
enhanced by encapsulating it into the box.
A tubular DNA origami
nanocarrier [60].
The carrier acts as a host
for luciferase enzymes.
Luminescence of the cargo can be
modulated by coating the carrier
with cationic polymers.
A box-like DNA origami
container [61].
The box facilitates the binding of
proteins (such as bovine serum albumin
(BSA)) in the cavity of the origami.
Bound proteins can be released by light.
A switchable DNA cage [62]. The cage can trap and release HRPthrough a conformational change.
The conformational change can
be controlled by temperature.
A β-galactosidase (β-gal) protein
coated by DNA strands [63].
DNA-coating significantly increases
cellular delivery of the enzymes.
The approach is highly modular,
and importantly, the enzymes retain
their activity in the transfection.
5.1. DNA Containers for Enzymes
Andersen et al. were the first to generalize the DNA origami technique to 3D objects [56].
They created a DNA box (42 ˆ 36 ˆ 36 nm3 in size) that can be opened by introducing the specific
DNA ‘keys’. Six DNA origami sheets were folded along the single-stranded M13 scaffold and
further assembled into a 3D box with a lid (Figure 5a, right). The lid was functionalized with a
dual lock-key system comprised of double-helices with single-stranded extensions. The attachment
of two fluorophores, Cy3 and Cy5, to the adjacent faces of the box enabled the detection of the lid
opening and closing by fluorescence resonance energy transfer (FRET).
Ke et al. [57] presented a 3D molecular cage with tetrahedron geometry (estimated inside volume
of 1.5 ˆ 10´23 m3 closed by triangular faces). The DNA tetrahedron was assembled in a single-step
process where the scaffold DNA, forming four planar adjacent triangular faces, was mixed together
with ssDNA staple strands and slowly annealed to form a desired shape. Figure 5a (left) shows a
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3D schematic drawing of the scaffold arrangement in the DNA tetrahedron with seams eliminated.
Moreover, Kuzuya and Komiyama [58] fabricated a box-shaped 3D DNA origami by folding the
scaffold strand into an open complex of two tetrahedral motifs and then selectively closed the box by
adding the appropriate staple strands. The size of the resulting 3D origami (45 ˆ 42 ˆ 35 nm3) is quite
similar to that of the virus capsids. In general, these DNA containers could enable the selective capture
of various guest molecules inside the motif, and they might be suitable for, e.g., harboring enzymes.
DNA containers could efficiently protect the enzymes from biological degradation through proteases
while maintaining their activities since small substrates can access the container through the small
openings in the DNA mesh.
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(b) Two half-cages equipped with glucose oxidase (GOx, orange) and horseradish peroxidase (HRP,
green) can form a clos d box and encapsulate the enzymes. The closed box efficie tly protects the
assemb ed nzyme casc de pair from protease dig stion [59]; (c) A DNA rigami-b sed nanocarrier
loaded with luciferase (LUC) enzymes. The enzyme activity can be tuned by coating the carrier
with cationic polymers [60]; (d) A light-triggered release of proteins such as bovine serum albumin
(BSA) from DNA origami container [61]; (e) A DNA cage that can trap and release an enzyme (HRP)
through the temperature-controlled conformational changes [62]; (f) β-galactosidase (β-gal) can be
coated by DNA strands for significantly enhanced cellular delivery [63]. A box with a lid in (a) is
reproduced with permission from [56]. Copyright Nature Publishing Group, 2009. A tetrahedron
in (a) is reproduced with permission from [57]. Copyright American Chemical Society, 2009. (b) is
reproduced with permission from [59]. Published by Nature Publishing Group, 2016. (c) is reproduced
with permission from [60]. Copyright The Royal Society of Chemistry, 2016. (d) is reproduced with
permission from [61]. Copyright American Chemical Society, 2016. (e) is reproduced with permission
from [62]. Copyright American Chemical Society, 2013. (f) is repro uced with permission from [63].
Co yright American Chemical Society, 2015.
Zhao et al. [59] showed how an active GOx-HRP enzyme cascade pair can be encapsulated and
protected from protease digestion using a designer DNA cage. The enzymes were attached to DNA
origami–based half-cages (Figure 5b) and the complementary halves were subsequently combined
into a cubic DNA box/cage. The walls of the design contain nanopore-like channels that allow the
diffusion of small molecules, such as substrates and products, but block the proteases. The cage was
tested with six different metabolic enzymes and, as the result, five of the six tested enzymes exhibited
turnover numbers four- to ten-fold higher than that of the free enzyme.
Kiviaho et al. [60] fabricated a hexagonal and tubular DNA origami carrier, which was equipped
with streptavidin-Lucia enzymes via biotinylated binding sites (Figure 5c). Enzyme-loaded DNA
origami was coated with three different cationic polymers (PDMAEMA, PDMAEMA-PEG and
PDMAEMA-PEG-PDMAEMA) through electrostatic interactions. The authors studied the effect
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of different polymer coatings on the luminescence decay rates of luciferase (LUC) enzymes (attached
to DNA origami). LUC enzymes showed appropriate catalytic activity in all samples with different
polymer concentrations (0, 10, 100 and 1000 polymers per DNA origami), indicating that the added
polymers are not capable of blocking the enzyme activity completely. By adjusting the amount of
polymer in the coating, it was possible to tune the characteristic enzymatic reaction rates of the
enzymes. Moreover, it was shown that the polymer-origami complexes and the polymers themselves
were not significantly toxic to human epithelial cells.
Kohman et al. [61] introduced a method to encapsulate bioactive molecules such as streptavidin
and bovine serum albumin (BSA) within DNA nanostructures and release them using short (<60 s)
pulses of light (Figure 5d). The strategy involved organic photolabile linker, which was reacted
with cargo molecules and subsequently conjugated to oligonucleotides, allowing the cargo to be
incorporated into a preassembled DNA origami cage (41ˆ 30ˆ 21 nm3 in size) through 14 addressable
ssDNA extensions in its cavity. This technique was shown to release cargo in its unaltered, bioactive
state in contrast to existing labile conjugation chemistries, which often interfere with the natural
bioactivity of the cargo.
5.2. Cellular Delivery of DNA-Enzyme Conjugates
To date, various DNA nanostructures have been successfully transfected into cells in vitro and
in vivo [64,65]. Moreover, the transfection rates of intrinsically polar DNA structures could be
tuned/enhanced by cationic polymers [60], intercalators [66], lipid membrane formulations [67]
and virus capsid proteins [68]. However, so far there exist only a few reported approaches of delivering
functional enzymes into cells by taking advantage of DNA nanostructures.
Juul et al. [62] developed a preassembled DNA cage that can encapsulate and release enzymes by
temperature-induced conformational changes in the assembly (illustrated in Figure 5e). The cage-like
structure was assembled using 12 DNA duplexes that formed the edges of the design. In between the
double-stranded domains, there were short ssDNA linkers that made up five cage corners, but the
one corner was composed of four 32-nt-long stretches of DNA possessing a sequence that enables
hairpin-formation. The hairpin structure was formed only below 22 ˝C (the annealing temperature
of the hairpin-forming sequences), and thus it allowed temperature-controlled switching between
the open and closed states. It was demonstrated that the HRP enzyme could enter or exit the cage
at 37 ˝C, but it stayed trapped in the cage when the temperature was lowered to 4 ˝C (four different
states depicted in Figure 4e). In addition, Juul et al. studied if the DNA cage could improve the cellular
uptake of HRP enzymes. However, it was observed that the cellular uptake was facilitated only in the
presence of Lipofectamine® transfection agent.
Brodin et al. [63] (Figure 5f) showed that cellular delivery of β-galactosidase (β-gal) can be
enhanced by coating it with a dense shell of oligonucleotides. The large homotetrameric enzyme
was reacted with an excess of a thiol-reactive fluorophore (AF647 maleimide), affording a tetramer
with fluorophore modifications (AF4-β-gal). Fluorophores allow the quantification of the protein
concentration after modification with oligonucleotides and they provide a handle for monitoring
cellular uptake. The formed AF4-β-gal surface was coated with short PEG chain –modified DNA
strands (dGGT)10 yielding a conjugate ProSNA β-gal with ca. 25 strands of DNA per each tetrameric
enzyme (ProSNA β-gal depicted in Figure 4f). The enhancement in the cellular uptake of the complex
(~280-fold) resulted from its ability to engage scavenger receptors, which are found on the surfaces
of most cells. Importantly, β-gal maintained its catalytic functionality in the transfection process.
The method could be generalized to other enzymes as well because the technique does not rely on the
properties of the core molecule but, instead, merely on the 3D architecture of the conjugate.
6. Conclusions
Rapid development in the field of structural DNA nanotechnology has recently enabled the
controlled self-assembly of complex and functional nano-objects. Unlike most other man-made
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self-assembled structures, the precise and programmable base-pairing of DNA can be utilized to
produce diverse non-symmetric and non-periodic architectures that allow the positioning of functional
units with nanometer-level precision. In this review, we have discussed how this compelling property
of DNA can be used to control the positioning of enzymes and, furthermore, to affect their capability
to catalyze reactions. We hope the discussion and examples presented here provide insight to the
relatively young field of DNA-based enzyme reactors and systems, which is currently under heavy
development. Some of the hurdles related to the positioning of enzymes and controlling their reactivity
have already been solved; however, we expect to see even greater progress in studying how these
conjugates, reactors and other systems behave in connection with living organisms.
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